Breakthroughs and Breakthroughs

Barry Palevitz's and Ricki Lewis's article about scientific breakthroughs1 raises important issues. The authors give many examples of overconfidence from journalists. They refer to talks from the Breakthrough! conference at Cold Spring Harbor Laboratory for scientists and journalists.2 They also discuss the Worlds Apart study from the Freedom Forum's First Amendment Center in Nashville, Tenn.3 At the end of their article, speaking about distrust between scientists and journalists, they ponder,

Written byAnn Barber
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Barry Palevitz's and Ricki Lewis's article about scientific breakthroughs1 raises important issues. The authors give many examples of overconfidence from journalists. They refer to talks from the Breakthrough! conference at Cold Spring Harbor Laboratory for scientists and journalists.2 They also discuss the Worlds Apart study from the Freedom Forum's First Amendment Center in Nashville, Tenn.3 At the end of their article, speaking about distrust between scientists and journalists, they ponder, "How long can that last?"

Maybe a third group of professionals can help allay this distrust. Investors use news from journalists and data from scientists to make their investment decisions. Just as scientists succeed when their work becomes a breakthrough, investors succeed when they invest in a true breakthrough and fail when they invest in hype. I am a physician-scientist who moved from Washington, D.C., to New York to become a biotech security analyst on Wall Street.4 After the overly ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies